Northwest & Ethical Investments’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.78M | Sell |
72,550
-1,800
| -2% | -$193K | 0.19% | 141 |
|
|
2025
Q1 | $7.5M | Sell |
74,350
-78
| -0.1% | -$7.87K | 0.2% | 142 |
|
|
2024
Q4 | $6.65M | Buy |
74,428
+330
| +0.4% | +$29.5K | 0.18% | 162 |
|
|
2024
Q3 | $6.21M | Buy |
74,098
+35,336
| +91% | +$2.96M | 0.16% | 163 |
|
|
2024
Q2 | $2.99M | Buy |
38,762
+33,366
| +618% | +$2.57M | 0.09% | 212 |
|
|
2024
Q1 | $370K | Buy |
+5,396
| New | +$370K | 0.01% | 357 |
|
|
2017
Q3 | – | Sell |
-5,138
| Closed | -$142K | – | 353 |
|
|
2017
Q2 | $142K | Buy |
5,138
+900
| +21% | +$24.9K | 0.01% | 331 |
|
|
2017
Q1 | $105K | Sell |
4,238
-1,600
| -27% | -$39.8K | 0.01% | 348 |
|
|
2016
Q4 | $126K | Buy |
+5,838
| New | +$126K | 0.01% | 342 |
|